A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-07-15
著者
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
KATO Junji
Sapporo Medical University Hospital
-
MEGURO KUNIAKI
National Sendai Hospital
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
NAKAO Shinji
Kanazawa University Hospital
-
URABE Akio
NTT Kanto Medical Center
-
MIYAMURA Koichi
Japanese Red Cross Nagoya First Hospital
-
TANII Hiromi
Novartis Pharma Japan
-
Taguchi Hirokuni
浜松医科大学 内科学第3
-
Hotta T
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Hata Tomoko
Nagasaki University
-
Hata Tomoko
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Oshimi Kazuo
Division Of Hematology Department Of Internal Medicine Juntendo University School Of Medicine
-
Meguro Kuniaki
東北大学 医学部分子診断学
-
Sahara Naohi
浜松医科大学 内科学第3
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
IWATO Koji
Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Ozawa K
Division Of Genetic Therapeutics Center For Molecular Medicine Jichi Medical University
-
Ozawa Keiyo
Department Of Hematology Jichi Medical School
-
Ozawa Keiya
Jichi Medical School
-
Tanii Hiromi
Novartis Pharma K.k.
-
Tatsumi Yoichi
Kinki University
-
MIYAZAWA Keisuke
First Department of Internal Medicine, Tokyo Medical University
-
Miyamura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Miyamura K
Tohoku Univ. School Of Medicine Sendai Jpn
-
Miyamoto Ken-ichi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Nakao Shinji
Department Of Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Scienc
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
ISHIKAWA Takayuki
Kyoto University
-
MORI Hiraku
Showa University Fujigaoka Hospital
-
KONDO Midori
Novartis Pharma K.K.
-
TANIGUCHI Junsuke
Novartis Pharma K.K.
-
ROJKJAER Lisa
Novartis Pharma A.G.
-
OMINE Mitsuhiro
Showa University Fujigaoka Hospital
-
Kato Junji
Sapporo Medical University
-
Miyamura Koichi
東北大学 医学系研究科血液･免疫病学分野
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ozawa Keiya
Department Of Hematology Jichi Medical School
-
Taguchi Hirokuni
Department Of Internal Medicine Kochi Medical School
-
Hata Tomoko
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Miyazawa Keisuke
First Department Of Internal Medicine Tokyo Medical University
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
URABE Akio
Division of Hematology, NTT Kanto Medical Center
-
Ohyashiki Kazuma
First Deparmtne Of Internal Medicine Tokyo Medical University
-
Omine M
Showa Univ. Fujogaoka Hospital Yokohama Jpn
-
Ozawa K
Division Of Hematology Department Of Medicine Jichi Medical University
-
Maki Kazuhiro
Department Of Hematology Dokkyo University School Of Medicine
-
Ozawa Keiya
Jichi Medical Univ. Tochigi Jpn
-
Inamoto Takashi
Department Of Hematology And Oncology Graduate School Of Medicine Kyoto University
-
Urabe A
Ntt Kanto Medical Center
-
Hotta Tomomitsu
Nagoya Medical Center Nagoya Jpn
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Nakamura Satoko
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Miyazaki Koji
Department Of Hematology Kitasato University Hospital
-
Tatsumi Yoichi
Kinki Univ. Osaka Jpn
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
- Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
- Endobronchial Minute Leiomyoma in a Patient with Malignant Lymphoma
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
- Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Pulmonary non-caseating granuloma in Waldenstrom macroglobulinemia
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Disparity Between the Macroglobulin-Producing Components of 2 Cases of Follicular Lymphoma With Waldenstrom's Macroglobulinemia
- Homeobox genes in hematopoiesis and leukemogenesis
- Myeloid/Natural Killer Cell Precursor Acute Leukemia Accompanied by Homozygous Protein C Deficiency
- Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
- Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
- IgA-λ/IgG-к Biclonal Myeloma in which Two Clones Proliferated in Individual Sites
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
- Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
- Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
- The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
- The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
- Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
- Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol
- Trisomy 11 Acute Myeloid Leukemia: 5 Additional Cases From the Japan Adult Leukemia Study Group AML-92 and AML-95 Databases
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens
- Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
- Myelodysplastic Syndrome Accompanied by Addison's Disease and Multiple Autoimmune Phenomena: Steroid Therapy Resolved Cytopenias and All Immune Disorders
- Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
- Brain Abscess in Acute Myeloid Leukemia
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2^* magnetic resonance
- A Long-Survival Case of Systemic AL Amyloidosis with Nephrotic Syndrome
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95